Suffolk Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Suffolk Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-185,321	Closed	-$9.9M	–	170
2016 Q1	$9.9M	Buy	185,321 +171,789	+1,270%	+$12.7M	1.31%	27
2015 Q4	$1.53M	Sell	13,532 -5,894	-30%	-$649K	0.19%	129
2015 Q3	$2.29M	Buy	+19,426	New	+$2.54M	0.3%	98

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Suffolk Capital Management's ANAC Position: Q2 2016 in Review

Suffolk Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 185,321 shares — an estimated $9.9M sold.

Suffolk Capital Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $9.9M in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Suffolk Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Suffolk Capital Management sold 185,321 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $9.9M.
Suffolk Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
Suffolk Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $9.9M in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Suffolk Capital Management's 13F filing for Q2 2016, filed 8 Aug 2016.